BerGenBio Past Earnings Performance

Past criteria checks 0/6

BerGenBio's earnings have been declining at an average annual rate of -0.2%, while the Biotechs industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 72.1% per year.

Key information

-0.2%

Earnings growth rate

23.4%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate-72.1%
Return on equity-88.7%
Net Margin-29,828.2%
Next Earnings Update13 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BerGenBio makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7BG0 Revenue, expenses and earnings (NOK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-155440
31 Mar 241-155480
31 Dec 230-190510
30 Sep 230-226610
30 Jun 230-258600
31 Mar 230-293640
31 Dec 220-302640
30 Sep 221-294620
30 Jun 221-304740
31 Mar 221-309710
31 Dec 211-309710
30 Sep 211-314710
30 Jun 211-311610
31 Mar 211-290570
31 Dec 201-257520
30 Sep 200-241480
30 Jun 200-218400
31 Mar 200-204380
31 Dec 199-199350
30 Sep 1911-193320
30 Jun 1911-186360
31 Mar 1911-182330
31 Dec 182-192320
30 Sep 180-188320
30 Jun 180-186290
31 Mar 180-171280
31 Dec 170-182280
30 Sep 170-162210
30 Jun 170-142160
31 Mar 170-175140
31 Dec 160-130120
30 Sep 160-127180
30 Jun 160-128220
31 Mar 160-82240
31 Dec 150-72230
30 Sep 150-70200
30 Jun 150-64170
31 Mar 151-57150
31 Dec 141-58150

Quality Earnings: 7BG0 is currently unprofitable.

Growing Profit Margin: 7BG0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7BG0 is unprofitable, and losses have increased over the past 5 years at a rate of 0.2% per year.

Accelerating Growth: Unable to compare 7BG0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7BG0 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-13.8%).


Return on Equity

High ROE: 7BG0 has a negative Return on Equity (-88.67%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies